Rheumatoid arthritis exhibits reduced acute phase and enhanced constitutive serum amyloid A protein in synovial fluid relative to serum. A comparison with C-reactive protein

Journal of Rheumatology

Volumn 24, Issue 1, 1997, Pages 14-19

  Kumon, Yoshitaka ^a   Loose, Leland D ^b   Birbara, Charles A ^c   Sipe, Jean D ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

acute phase response; amyloid protein SAA; catabolism; rheumatoid arthritis; synovial fluid

Indexed keywords

AMYLOID A PROTEIN; C REACTIVE PROTEIN;

ACUTE PHASE RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ACUTE-PHASE PROTEINS; APOLIPOPROTEINS A; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; CELL COUNT; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; SERUM AMYLOID A PROTEIN; SYNOVIAL FLUID;

EID: 0031026962     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Levin M, Pras M, Franklin EC: Immunologic studies of major nonimmunoglobulin protein of the amyloid. I. Identification and partial characterization of a related serum component. J Exp Med 1973;138:373-80.
2. Strachan AF, de Beer FC, van der Westhuyzen DR, Coetzee GA: Identification of three isoform patterns of human serum amyloid A protein. Biochem J 1988;250:203-7.
3. Strachan AF, Brandt WF, Woo P, et al: Human serum amyloid A protein. The assignment of six major isoforms to three published gene sequences and evidence for two genetic loci. J Biol Chem 1989;264:18368-73.
4. Whitehead AS, de Beer MC, Steel DM, et al: Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J Biol Chem 1992;267-3862-7.
5. Sipe D: The acute phase response in the pathogenesis of inflammatory disease: Prospects for pharmacotherapy. Clin Immunother 1995;3:297-307.
6. Loose LD, Sipe JD, Kirby DS, et al: Reduction of acute-phase proteins with tenidap sodium, a cytokine-modulating anti-rheumatic drug. Br J Rheumatol 1993;(suppl 3)32:19-25.
7. Badolato R, Wang JM, Murphy WJ, et al: Serum amyloid A is a chemoattractant: Induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 1994;180:203-9.
8. Benditt EP, Eriksen N: Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc Natl Acad Sci USA 1977;74:4025-8.
9. Coetzee GA, Strachan AF, van der Westhuyzen DR, Hoppe HC, Jennah MS, de Beer FC: Serum amyloid A-containing human high density lipoprotein 3. Density, size and apolipoprotein composition. J Biol Chem 1986;261:9644-51.
10. Kumon Y, Suehiro T, Ikeda Y, Yoshida K, Hashimoto K, Ohno F: Influence of serum amyloid A protein on high density lipoprotein in chronic inflammatory disease. Clin Biochem 1993;26:501-11.
11. Bausserman LL, Herbert PN, Rodger R, Nicolosi RJ: Rapid clearance of serum amyloid A from high-density lipoproteins. Biochim Biophys Acta 1984;792:186-91.
12. Tape C, Kisilevsky R: Apolipoprotein A-I and apolipoprotein SAA half-lives during acute inflammation and amyloidosis. Biochim Biophys Acta 1990;1043:295-300.
13. Cabana VG, Siegel JN, Sabesin SM: Abnormal HDL generated during the acute phase response (abstr). Arteriosclerosis 1990-10:764.
14. Small DM, Cohen AS, Schmid K: Lipoproteins of synovial fluid as studied by analytical ultracentrifugation. J Clin Invest 1964;43:2070-9.
15. Prete PE, Gurakar-Osborne A, Kashyap ML: Synovial fluid lipoproteins: Review of current concepts and new directions. Semin Arthritis Rheum 1993;23:79-89.
16. Sukenik S, Henkin J, Zimlichman S, et al: Serum and synovial fluid levels of amyloid A protein C-reactive protein in inflammatory and noninflammatory arthritis. J Rheumatol 1988;15:942-5.
17. Sipe JD, Gonnerman WA, Loose LD, Knapschaefer G, Xie WJ, Franzblau C; Direct binding enzyme-linked immunosorbent assay for serum amyloid A. J Immunol Methods 1989;125:125-35.
18. 4) as apolipoprotein. J Lipid Res 1995;36:526-34.
19. de Oliveira RM, Sipe JD, Loose LD, et al: A rapid, sensitive enzyme-linked immunosorbent assay for serum amyloid A in human plasma and tissue culture fluids. Amyloid: Int J Exp Clin Invest 1994;1:23-9.
20. 4: Its constitutive presence in serum. Amyloid: Int J Exp Clin Invest 1994;1:114-8.
21. Prete PE, Ananth L, Kashyap ML: Apolipoproteins AI and B and cholesterol in synovial fluid. Metabolism 1993;42:803-6.
22. Terkeltaub RA, Dyer CA, Martin J, Curtiss LK: Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular Apo E and demonstration of Apo E binding to urate crystals in vivo. J Clin Invest 1991;87:20-6.